Kai‐Chia Yeh

508 citations
18 papers · 315 indexed · h-index 11

Kai‐Chia Yeh

18 papers receiving 301 citations

Peers

Kai‐Chia Yeh
Comparison fields: 5 of 55
  • Oncology 163
  • Molecular Biology 113
  • Immunology 74
  • Organic Chemistry 53
  • Pulmonary and Respiratory Medicine 53
Replace Rosemary Mayer‐Ezell with:
Rosemary Mayer‐Ezell United States
Jean‐Michel Luccarini France
Ivana Galetić Switzerland
Y Yamaguchi Japan
M. Anthony Leesnitzer United States
Gillian Moore Ireland
Luca A. Petruccelli Canada
Josephine Pelletier United States
Shin-ichi Kaiho Japan
Zsolt Kasza Sweden
Kai‐Chia Yeh relative to Rosemary Mayer‐Ezell United States Rosemary Mayer‐Ezell's profile →
Citations per field
00.5×1.5×2.3×
Rosemary Mayer‐Ezell · 1×
Citations per year

Countries citing papers authored by Kai‐Chia Yeh

Since Specialization
Citations

This map shows the geographic impact of Kai‐Chia Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Chia Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Chia Yeh more than expected).

Fields of papers citing papers by Kai‐Chia Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Chia Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Chia Yeh. The network helps show where Kai‐Chia Yeh may publish in the future.

Co-authorship network of co-authors of Kai‐Chia Yeh

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Chia Yeh. A scholar is included among the top collaborators of Kai‐Chia Yeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Chia Yeh. Kai‐Chia Yeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 10
2 9
3 2
4 60
5 10
6 11
7 30
8 10
9 27
10 19
11 18
12 15
13
Antiangiogenic activities and cisplatin-combined antitumor activities of BPR0L075.
12
14 31
15 7
16 7
17 22
18 15

About Kai‐Chia Yeh

Kai‐Chia Yeh is a scholar working on Oncology, Cellular and Molecular Neuroscience and Hematology, having authored 18 papers that have together received 315 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (5 papers), Peptidase Inhibition and Analysis (5 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Oncology (163 citations), Immunology (74 citations) and Endocrinology, Diabetes and Metabolism (40 citations). Kai‐Chia Yeh has collaborated with scholars based in Taiwan and India. Frequent co-authors include Chiung‐Tong Chen, Jen‐Shin Song, Kak‐Shan Shia, Teng‐Kuang Yeh, Min‐Hsien Wang, Yu‐Sheng Chao, Kuan‐Wei Huang, Jing‐Kai Huang, Chih-Chun Chang and Tsu Hsu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026